Evidence map›Paper›PMID 33346865›Full record

ArticleAdvances in biochemical engineering/biotechnology2021

Digital Twins in Biomanufacturing.

Steffen Zobel-Roos, Axel Schmidt, Lukas Uhlenbrock, Reinhard Ditz, Dirk Köster, Jochen Strube

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in biochemical engineering/biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Steffen Zobel-RoosInstitute for Separation and Process Technology, Clausthal University of Technology, Clausthal-Zellerfeld, Germany.
Axel SchmidtInstitute for Separation and Process Technology, Clausthal University of Technology, Clausthal-Zellerfeld, Germany.
Lukas UhlenbrockInstitute for Separation and Process Technology, Clausthal University of Technology, Clausthal-Zellerfeld, Germany.
Reinhard DitzInstitute for Separation and Process Technology, Clausthal University of Technology, Clausthal-Zellerfeld, Germany.
Dirk KösterInstitute for Separation and Process Technology, Clausthal University of Technology, Clausthal-Zellerfeld, Germany.
Jochen StrubeInstitute for Separation and Process Technology, Clausthal University of Technology, Clausthal-Zellerfeld, Germany. strube@itv.tu-clausthal.de.
Clausthal University of Technology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years process modelling has become an established method which generates digital twins of manufacturing plant operation with the aid of numerically solved process models. This article discusses the benefits of establishing process modelling, in-house or by cooperation, in order to support the workflow from process development, piloting and engineering up to manufacturing. The examples are chosen from the variety of botanicals and biologics manufacturing thus proving the broad applicability from variable feedstock of natural plant extracts of secondary metabolites to fermentation of complex molecules like mAbs, fragments, proteins and peptides.Consistent models and methods to simulate whole processes are available. To determine the physical properties used as model parameters, efficient laboratory-scale experiments are implemented. These parameters are case specific since there is no database for complex molecules of biologics and botanicals in pharmaceutical industry, yet.Moreover, Quality-by-Design approaches, demanded by regulatory authorities, are integrated within those predictive modelling procedures. The models could be proven to be valid and predictive under regulatory aspects. Process modelling does earn its money from the first day of application. Process modelling is a key-enabling tool towards cost-efficient digitalization in chemical-pharmaceutical industries.

Indexed as

Biological ProductsDrug IndustryQuality ControlWorkflowBiological ProductsChemical-pharmaceutical industryDigitalizationDigital twinIndustry 4.0Process modelling

Identifiers

PMID33346865
OpenAlexW3114451864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.